Medical specialists from France tagged as investigators in clinical trials studying Small Cell Lung Cancer

Total 91 results

Marie MARCQ, Doctor
Seen in:
- La Roche Sur Yon, Centre Hospitalier Les Oudairies
Trials:
- NCT00418743 (Sub-Investigator)
Conditions:
- Small Cell Lung Cancer
Marie WISLEZ, Pr
Seen in:
- Ile De France, Paris, Assistance Publique - Hôpitaux de Paris (AP-HP) - Cochin Hospital - Pneumology unit
- Paris, Paris - Hôpital Cochin
Trials:
- NCT05856695 (Principal Investigator)
- NCT06053099 (Principal Investigator)
- NCT06244355 (Principal Investigator)
Conditions:
Marielle Le Bon, MD
Seen in:
- Pierre Benite Cedex, CHU de Lyon - Hopital Lyon Sud (UNICANCER)
Trials:
- NCT04790253 (Principal Investigator)
Conditions:
- Extensive-stage Small-cell Lung Cancer;
- Limited Stage Small Cell Lung Cancer
Mostefa Bennamoun, MD
Seen in:
- Paris, Institut Mutualiste Montsouris
Trials:
- NCT05551117 (Principal Investigator)
Conditions:
Olivier BYLICKI, Dr
Seen in:
- Toulon, Toulon - Sainte Anne HIA
Trials:
- NCT05856695 (Principal Investigator)
Conditions:
- Small Cell Lung Cancer Extensive Stage
Olivier LELEU, Dr
Seen in:
- Abbeville, Abbeville - CH
Trials:
- NCT05856695 (Principal Investigator)
Conditions:
- Small Cell Lung Cancer Extensive Stage
Olivier MOLINIER, Dr
Seen in:
- Le Mans, Le Mans - CHG
Trials:
- NCT05856695 (Principal Investigator)
Conditions:
- Small Cell Lung Cancer Extensive Stage
Pascal ASSOULINE, Doctor
Seen in:
- Longjumeau, Centre Hospitalier Régional
Trials:
- NCT00418743 (Sub-Investigator)
Conditions:
- Small Cell Lung Cancer
Pascal THOMAS, Doctor
Seen in:
- GAP, Site 04
Trials:
- NCT00418743 (Principal Investigator)
Conditions:
- Small Cell Lung Cancer
Philippe ASTOUL, Professor
Seen in:
- Marseille, Site 06
Trials:
- NCT00418743 (Sub-Investigator)
Conditions:
- Small Cell Lung Cancer
Philippe BARTHELEMY, MD
Seen in:
- Bas Rhin, Strasbourg, Institut de cancérologie Strasbourg Europe (ICANS)
- Strasbourg, Institut de cancerologie Strasbourg Europe
Trials:
- NCT05551117 (Principal Investigator)
- NCT06379880 (Principal Investigator)
Conditions:
Philippe DAVID, Professor
Seen in:
- Elbeuf, Site 32
Trials:
- NCT00418743 (Principal Investigator)
Conditions:
- Small Cell Lung Cancer
Philippe MASSON, Dr
Seen in:
- Cholet, Cholet - CH
Trials:
- NCT05856695 (Principal Investigator)
Conditions:
- Small Cell Lung Cancer Extensive Stage
Philippe ROMAND, Dr
Seen in:
- Contamine-sur-Arve, Annemasse - CH
Trials:
- NCT05856695 (Principal Investigator)
Conditions:
- Small Cell Lung Cancer Extensive Stage
Pierre Boisselier, MD
Seen in:
- Montpellier, Institut du Cancer de Montpellier (UNICANCER)
Trials:
- NCT04790253 (Principal Investigator)
Conditions:
- Extensive-stage Small-cell Lung Cancer;
- Limited Stage Small Cell Lung Cancer
Pierre J SOUQUET, Professor
Seen in:
- Lyon, Centre Hospitalier Lyon Sud
Trials:
- NCT00418743 (Sub-Investigator)
Conditions:
- Small Cell Lung Cancer
Pourel Nicolas, MD
Seen in:
- Avignon, Institut Sainte Catherine
- Avignon, Institut Sainte Catherine (UNICANCER)
Trials:
- NCT04790253 (Principal Investigator)
Conditions:
- Extensive-stage Small-cell Lung Cancer;
- Limited Stage Small Cell Lung Cancer
Radj GERVAIS, Doctor
Seen in:
- Caen, Centre François Baclesse
- Caen, Site 43
Trials:
- NCT00418743 (Principal Investigator)
Conditions:
- Small Cell Lung Cancer
Raffaele Ratta, MD
Seen in:
- Ile De France, Suresnes, Hôpital Foch
Trials:
- NCT05551117 (Principal Investigator)
Conditions:
Sabine Vieillot, MD
Seen in:
- Perpignan, Centre Catalan d'Oncologie (UNICANCER)
Trials:
- NCT04790253 (Principal Investigator)
Conditions:
- Extensive-stage Small-cell Lung Cancer;
- Limited Stage Small Cell Lung Cancer
Sandrine HIRET, MD
Seen in:
- Angers, ICO - Site Paul Papin
- Maine-et-Loire, Angers, Edog - Ico - Ppds
- Saint-Herblain, Institut de Cancerologie de l'Ouest- ICO
- Saint-Herblain, Institut de Cancérologie de l'Ouest
Trials:
- NCT04733027 (Principal Investigator)
- NCT04577638 (Principal Investigator)
- NCT05027867 (Principal Investigator)
- NCT04666961 (Principal Investigator)
Conditions:
Sebastian Couraud, MD
Seen in:
- Rhône, Lyon, Hospices Civils de Lyon
Trials:
- NCT05027867 (Principal Investigator)
Conditions:
Sébastien COURAUD, Pr
Seen in:
- Lyon, Lyon - URCOT
Trials:
- NCT05856695 (Principal Investigator)
Conditions:
- Small Cell Lung Cancer Extensive Stage
Sophie Cousin, MD
Seen in:
- Bordeaux Cedex, Institut Bergonie
- Bordeaux, EDOG - Institut Bergonie - PPDS
- Bordeaux, Institut Bergonie
- Bordeaux, Institut Bergonie - Centre Regional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest
Trials:
- NCT05403385 (Principal Investigator)
- NCT04880382 (Principal Investigator)
- NCT03475953 (Principal Investigator)
- NCT05668585 (Principal Investigator)
- NCT05027867 (Principal Investigator)
Conditions:
Stephanie Batard, MD
Seen in:
- Bordeaux, Institut Bergonie (UNICANCER)
Trials:
- NCT04790253 (Principal Investigator)
Conditions:
- Extensive-stage Small-cell Lung Cancer;
- Limited Stage Small Cell Lung Cancer
Thierry URBAN, Doctor
Seen in:
- Angers, Centre Hospitalier Universitaire
Trials:
- NCT00418743 (Principal Investigator)
Conditions:
- Small Cell Lung Cancer
Thureau Sebastien, MD
Seen in:
- Rouen, Centre Henri Becquerel (UNICANCER)
Trials:
- NCT04790253 (Principal Investigator)
Conditions:
- Extensive-stage Small-cell Lung Cancer;
- Limited Stage Small Cell Lung Cancer
Valérie GOUNANT, Dr
Seen in:
- Paris, Paris - APHP Bichat
- Paris, Paris - Bichat
Trials:
- NCT04108026 (Principal Investigator)
- NCT04111705 (Principal Investigator)
- NCT03977194 (Principal Investigator)
- NCT05856695 (Principal Investigator)
Conditions:
Xavier Artignan, MD
Seen in:
- Ille Et Vilaine, Saint-Grégoire, Centre Hospitalier Prive Saint-Gregoire
- Saint-Grégoire, CHP St Grégoire
Trials:
- NCT05551117 (Principal Investigator)
- NCT04764487 (Principal Investigator)
Conditions:

Clinical Trials on Small Cell Lung Cancer

AIO-Studien-gGmbH
Bristol-Myers Squibb; Eli Lilly and Company; Merck Sharp & Dohme LLC; Pfizer; Gilead... and other collaborators

Recruiting

Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients (CRISP)

Small-cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage I | Metastatic Non-small Cell Lung Cancer (NSCLC) | Non Small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer Stage II

Germany
University of Wisconsin, Madison
National Cancer Institute (NCI)

Completed

Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients

Stage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Extensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Healthy, no Evidence of Disease | Limited Stage Small Cell Lung... and other conditions

United States
WindMIL Therapeutics
Bristol-Myers Squibb

Terminated

Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs™ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLC

NSCLC | Lung Cancer | Lung Cancer Metastatic | Lung Cancer, Non-small Cell | Non Small Cell Lung Cancer | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non Small Cell Lung Cancer Metastatic

United States
National Cancer Institute (NCI)

Completed

FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer

Stage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Extensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer

United States
University of California, San Francisco
AstraZeneca

Active, not recruiting

Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery

Stage IIIA Non-Small Cell Lung Cancer | Stage I Non-Small Cell Lung Cancer | Stage IA Non-Small Cell Lung Cancer | Stage IB Non-Small Cell Lung Cancer | Stage II Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Cancer | Stage IIB Non-Small Cell Lung Cancer

United States
Washington University School of Medicine
Merck Sharp & Dohme LLC

Withdrawn

Personalized Therapeutic Anti-tumor Vaccine With Pembrolizumab and Standard of Care Chemotherapy in Squamous Non-Small Cell Lung Cancer and Extensive Stage Small Cell Lung Cancer

NSCLC | Non Small Cell Lung Cancer | Non-small Cell Lung Cancer | Small Cell Lung Extensive Stage
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer

Tobacco Use Disorder | Stage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Limited Stage Small Cell Lung Cancer | Stage IA Non-small Cell Lung Cancer | Stage IB Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB...

United States
Shanghai Chest Hospital

Recruiting

Molecular Analysis and Treatment Options of SCLC

Small Cell Lung Carcinoma | Small-cell Lung Cancer | Small Cell Lung Cancer Limited Stage | Small Cell Lung Cancer Extensive Stage | Small Cell Lung Cancer, Combined Type

China
National Cancer Institute (NCI)

Terminated

Erlotinib in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer Undergoing Surgical Resection

Stage IIIA Non-small Cell Lung Cancer | Stage IA Non-small Cell Lung Cancer | Stage IB Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung Cancer

United States
Alexander Chi

Not yet recruiting

Combining ICI With SBRT or HypoFrx-RT for ES NSCLC

Non-small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage I | Non-small Cell Carcinoma | Non-small Cell Lung Cancer Stage II

China

Medical specialists from France tagged as investigators in clinical trials studying Small Cell Lung Cancer

Clinical Trials on Small Cell Lung Cancer

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations